PROGRAM CHAIRS
Naim Alkhouri, MD, FAASLD, DABOM
Chief Academic Officer at Summit Clinical Research
Chief Medical Officer
Director, Fatty Liver Program
Chief of Transplant Hepatology
Westlake, Ohio
Sonal Kumar, MD, MPH
Assistant Professor of Medicine
Director of Clinical Hepatology
Weill Cornell Medical College
New York, New York
PROGRAM OVERVIEW
This highly interactive, case-based program provides clinicians with practical, guideline-aligned strategies for the early identification and management of metabolic dysfunction–associated steatohepatitis (MASH). Through expert presentations and case discussions, participants will learn how to use noninvasive tests to diagnose and stage disease, address key cardiometabolic comorbidities, and incorporate lifestyle and weight-loss interventions. The program also reviews evidence supporting newly available and emerging treatments, along with guidance on selecting appropriate candidates for pharmacologic therapy. Attendees will gain actionable insights to enhance care coordination and optimize outcomes for patients with or at risk for MASH.
TARGET AUDIENCE
This activity is intended for hepatologists and gastroenterologists.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Implement AASLD guideline recommendations to enable early MASH diagnosis, including MASH screening for at-risk individuals and the use of non-invasive diagnostic techniques, such as biomarker- and imaging-based testing
- Incorporate AASLD guideline recommendations for the medical management of MASH, including lifestyle modification and pharmacologic management recommendations, into clinical practice
- Analyze the efficacy and safety data from MASH clinical trials evaluating treatment with resmetirom or GLP-1 RAs for patients with MASH to inform the development of patient-centric, evidence-based treatment plans
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.5 ANCC contact hours.
PHARMACISTS AND PHARMACY TECHNICIANS (ACPE) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of up to 1.5 knowledge-based continuing pharmacy education (CPE) contact hours.
Note to pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (eg, name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Medical Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| Naim Alkhouri, MD, FAASLD, DABOM | Consulting Fees: 89bio, AbbVie, Akero Therapeutics, Boehringer Ingelheim, Echosens, Fibronostics, Gilead Sciences, HistoIndex, Intercept Pharmaceuticals, Ipsen, Madrigal Pharmaceuticals Speakers Bureau: AbbVie, AstraZeneca, Echosens, Gilead Sciences, Intercept Pharmaceuticals, Ipsen, Madrigal Pharmaceuticals, Perspectum Contracted Research: 89bio, Akero Therapeutics, Arbutus Biopharma, AstraZeneca, BioAge, Boehringer Ingelheim, Bristol Myers Squibb, Corcept Therapeutics, Galectin Therapeutics |
| Sonal Kumar, MD, MPH | Consulting Fees: Boehringer Ingelheim, Gilead Sciences, GSK, Ipsen, Madrigal Pharmaceuticals, Novo Nordisk Speakers Bureau: Gilead Sciences, GSK, Ipsen, Madrigal Pharmaceuticals, Novo Nordisk Contracted Research: Madrigal Pharmaceuticals, Novo Nordisk |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
- John Guerriero, Vice President of Innovation and Engagement for Med Learning Group, has nothing to disclose.
- Dominique Barton, BS, BSN, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Nicole Longo, DO, FACOI, VP Med/Sci Services & Learner Engagement for Med Learning Group, has nothing to disclose.
- Lauren Scott, Medical Director for Med Learning Group, has nothing to disclose.
- Abigail Dill, Program Manager for Med Learning Group, has nothing to disclose.
- Daniel DaSilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity.
In order to obtain a certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation.
Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use their clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group, prior to participating, at [email protected]
RELEASED DATE: December 11, 2025
EXPIRATION DATE: December 11, 2026
Copyright © 2025 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
